Lilly and Immunocore collaborate on melanoma
June 29, 2015Research and Development, Sales and Marketing LY2157299, LY2801653, brett wells, immunocore, lilly
Eli Lilly is teaming up again with UK biotech Immunocore in order to work together on immunotherapy-based clinical trials. Specifically …
UK pharma’s ‘Golden Triangle’ faces competition from new challengers
June 29, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioGateway, Cambridge, London, Oxford
The UK’s medical and scientific base is regarded as one of the world’s best.
Boehringer scores trial success for Pradaxa antidote
June 29, 2015Research and Development, Sales and Marketing Boehringer, Pradaxa, idarucizumab
Bosses at Boehringer Ingelheim say the latest results of a study of idarucizumab, and antidote for its blockbuster blood-thinner Pradaxa, …
Novartis spends $200m on pain firm Spinifex
June 29, 2015Sales and Marketing Cosentyx, EMA401, Novartis, Secukinumab, spinifex
Novartis is spending $200 million to increase its presence in pain management through the purchase of US-Australian biotech Spinifex Pharmaceuticals. …
Bayer’s Eylea approved in Japan
June 29, 2015Sales and Marketing Eylea, Japan, aflibercept. bayer
German firm Bayer has been shown the green light by the Japanese Ministry of Health, Labour and Welfare to market …
Synexus announces new board
June 29, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synexus, woler
Following a management buyout Synexus has confirmed who its new board members are to steer the UK recruitment and clinical …
EMA waves through a raft of drug recommendations
June 26, 2015Research and Development, Sales and Marketing AbbVie, Alexion, CHMP, EMA, Novartis, Novo Nordisk, brett wells
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended several treatments for marketing …
Valeant looking to buy Zoetis
June 26, 2015Sales and Marketing Actavis, Allergan, Valeant, Zoetis, brett wells
Canadian drugmaker Valeant Pharmaceuticals has made a move to acquire animal health company Zoetis. This is according to the Wall …
UK Court weighs in on Lilly-Actavis Alimta case
June 26, 2015Medical Communications, Sales and Marketing Actavis, Alimta, UK, lilly
Actavis will be infringing Lilly’s patent if it were to produce generic versions of Alimta, the UK Court of Appeal …
Hanover names branding and comms lead
June 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, frances beves
London-based healthcare communications agency Hanover has recruited Frances Beves as a director to join in August. Beves joins as a …
Red Door Unlimited hires new director
June 25, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kimberly Santiago, Paradigm Communications, Porter Novelli, red door unlimited
Red Door Unlimited has appointed a new director in Kimberly Santiago who joins from Porter Novelli’s sister agency Paradigm Communications. …
Lilly and Novartis face legal challenges
June 25, 2015Medical Communications, Sales and Marketing Gleevec, Glivec, Novartis, cymbalta, imatinib, lilly, zyprexa
Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …
Senior heads depart AstraZeneca and Takeda
June 25, 2015Medical Communications, Sales and Marketing AstraZeneca, Briggs Morrison, François-Xavier Roger, James Ward-Lilley, Takeda, brett wells
AstraZeneca vice president James Ward-Lilley and Takeda’s chief financial officer François-Xavier Roger are both exiting their respective companies and moving …
Sophia Genetics appoints chief financial officer
June 25, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Marylin Mermod Schule, Sophia Genetics
Swiss-based Sophia Genetics that deals in data driven medicine has appointed Marylin Mermod Schule to be its chief financial officer. …
China rejects Gilead’s Sovaldi patent
June 24, 2015Research and Development, Sales and Marketing China, Gilead, hep C, sofosbuvir, sovaldi
Manufacturer of the blockbuster hepatitis C treatment Sovaldi Gilead has seen its application for a patent in China rejected following …
NICE asks for more evidence from dry eye treatment maker
June 24, 2015Research and Development, Sales and Marketing Ikervis, NHS, NICE, ciclosporin, santen pharma
A NICE appraisal committee has asked for more information on a treatment for chronic dry eye syndrome, after failing to …
Google unveils its health wearable
June 24, 2015Medical Communications, Sales and Marketing Apple, brett wells, fitbit, gogle x, google, researchkit, study kit, wearable
Google has developed a health-tracking wearable that is not for the consumer market but rather designed to be utilised in …
OBN chief executive Jon Rees steps down
June 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OBN, jon rees, ross sommerville
UK life sciences membership organisation OBN has confirmed that its chief executive Jon Rees is stepping down in August after a decade …
Former Sanofi chief executive joins Waypoint
June 23, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Viehbacher, waypoint
The former Sanofi chief executive Christopher Viehbacher is joining Geneva-headquartered business enterprise firm Waypoint Capital as a managing partner.
Pfizer acquires meningitis vaccines from GSK
June 23, 2015Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, Pfizer, meningitis
Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
